课题基金 / 基金详情

Solid-state patch clamp platform to diagnose autism and screen for effective drug

Solid-state patch clamp platform to diagnose autism and screen for effective drug
用于诊断自闭症和筛选有效药物的固态膜片钳平台
批准号:
8701413
负责人:
John R Huguenard
金额:
$23.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-15 至 2016-05-31

项目摘要

项目成果

John R Huguenard的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Autism spectrum disorders (ASDs) have risen to approximately 1 in 88 in the Unites States over the past years, affecting an entire generation of children, families and communities. Currently, the diagnosis for most forms of ASD is based on a triad of behavioral symptoms, including social impairments, communication difficulties, and repetitive or stereotyped behaviors, with no quantitative measures for screening or assessment of potential drug therapies. Electrophysiological measurements of synapses and neuronal networks from these patients may hold the potential for diagnosing, characterizing and analyzing the effectiveness of potential treatment strategies. Here, we propose to apply a transformative technology for the long-term intracellular recording networks of neurons differentiated from patient-derived iPSC. To accomplish this goal, we have created a solid-state device comprised of 2D arrays of Stealth electrodes that sit passively within the membrane of neuronal cells and have the capacity to record synaptic, neuronal and network properties of multiple interconnected neurons simultaneously for days to weeks. Through the optimization of the fabrication of these Stealth probes and the transformation into a turn-key device, we will evaluate the feasibility of this platform as a diagnostic and research tool for ASD. We then propose to use this innovative scalable analytical platform to characterize the neuronal, synaptic and network signatures of neurons differentiated from iPS cells derived from patients with Phelan-McDermid Syndrome and then assess the effectiveness of emerging drug therapies to normalize aberrant signatures. If successful, our solid-state platform can be transformed into a high-throughput screening device that will allow investigators to recapitulate early developmental stages of ASD and evaluate the effects of ASD mutations and environmental insults on neuronal network and synaptic function and utilize this as a tool for drug screening, diagnosis and personalized treatment.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1523/jneurosci.0116-16.2016
发表时间: 2016-08-31
期刊: JOURNAL OF NEUROSCIENCE
影响因子: 5.3
作者: [Arons, Magali H., Lee, Kevin, Garner, Craig C.]
通讯作者: Garner, Craig C.
Chronic Axon Hypofunction in Maternal Immune Activation Models of Neurodevelopmental Disorders
  • 批准号:
    10401784
  • 项目类别:
  • 资助金额:
    $47.4万
  • 财政年份:
    2020
  • 负责人:
    John R Huguenard
  • 依托单位:
Chronic Axon Hypofunction in Maternal Immune Activation Models of Neurodevelopmental Disorders
  • 批准号:
    9916658
  • 项目类别:
  • 资助金额:
    $48.93万
  • 财政年份:
    2020
  • 负责人:
    John R Huguenard
  • 依托单位:
Chronic Axon Hypofunction in Maternal Immune Activation Models of Neurodevelopmental Disorders
  • 批准号:
    10601103
  • 项目类别:
  • 资助金额:
    $47.4万
  • 财政年份:
    2020
  • 负责人:
    John R Huguenard
  • 依托单位:
Limbic Circuit Dysfunction in Offspring following Maternal Immune Activation
  • 批准号:
    9314190
  • 项目类别:
  • 资助金额:
    $23.73万
  • 财政年份:
    2017
  • 负责人:
    John R Huguenard
  • 依托单位:
海外基金